US Stock MarketDetailed Quotes

CSBR Champions Oncology

Watchlist

5.225
+0.225+4.50%

Close Apr 16 16:00 ET

71.03MMarket Cap-7256P/E (TTM)

Champions Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jan 31, 2024

(Q2)Oct 31, 2023

(Q1)Jul 31, 2023

(FY)Apr 30, 2023

(Q4)Apr 30, 2023

(Q3)Jan 31, 2023

(Q2)Oct 31, 2022

(Q1)Jul 31, 2022

(FY)Apr 30, 2022

(Q4)Apr 30, 2022

Total revenue

-5.90%12.02M

-18.96%11.57M

-8.61%12.56M

9.69%53.87M

1.51%13.07M

-3.18%12.77M

21.17%14.28M

22.15%13.75M

19.66%49.11M

21.90%12.88M

Operating revenue

-7.76%11.18M

-19.73%10.88M

-7.19%11.88M

8.41%50.82M

-0.10%12.35M

-4.13%12.13M

21.60%13.55M

19.30%12.8M

18.27%46.88M

33.17%12.37M

Cost of revenue

1.95%7.85M

-11.08%6.62M

8.96%7.68M

24.97%29.53M

17.96%7.34M

20.18%7.7M

32.70%7.44M

30.69%7.05M

10.19%23.63M

6.47%6.22M

Gross profit

-17.82%4.17M

-27.54%4.96M

-27.13%4.88M

-4.47%24.34M

-13.87%5.73M

-25.24%5.07M

10.70%6.84M

14.27%6.69M

30.02%25.48M

40.99%6.66M

Operating expense

-10.42%6.75M

1.16%6.91M

6.48%7.43M

15.75%28.79M

6.89%7.45M

26.44%7.53M

15.51%6.83M

15.67%6.98M

29.34%24.87M

29.76%6.97M

Selling and administrative expenses

5.33%4.56M

3.97%4.4M

13.35%4.64M

11.27%17.24M

5.00%4.6M

14.67%4.33M

16.93%4.23M

9.71%4.09M

28.79%15.5M

32.69%4.38M

-Selling and marketing expense

2.04%1.8M

5.59%1.8M

0.24%1.7M

9.77%7M

14.49%1.85M

13.69%1.76M

3.66%1.7M

7.50%1.69M

15.56%6.38M

9.71%1.62M

-General and administrative expense

7.59%2.76M

2.89%2.6M

22.60%2.94M

12.32%10.24M

-0.54%2.75M

15.36%2.57M

27.95%2.53M

11.33%2.4M

40.00%9.12M

51.20%2.76M

Research and development costs

-31.73%2.19M

-3.42%2.52M

-3.26%2.79M

23.16%11.55M

10.07%2.85M

46.81%3.2M

13.27%2.6M

25.30%2.89M

30.27%9.37M

25.11%2.59M

Operating profit

-4.84%-2.58M

-28,028.57%-1.96M

-798.59%-2.55M

-832.95%-4.45M

-451.13%-1.71M

-396.14%-2.46M

-97.34%7K

-62.29%-284K

65.85%607K

52.01%-311K

Net non-operating interest income expense

Other net income (expense)

61.11%58K

-1,066.67%-105K

177.78%14K

-3,308.33%-818K

-2,262.86%-827K

212.50%36K

-134.62%-9K

-205.88%-18K

-133.80%-24K

-600.00%-35K

Special income (charges)

----

---807K

----

--0

----

-Write off

----

--807K

----

--0

----

Other non- operating income (expenses)

61.11%58K

-1,066.67%-105K

177.78%14K

54.17%-11K

42.86%-20K

212.50%36K

-134.62%-9K

-205.88%-18K

-133.80%-24K

-600.00%-35K

Income before tax

-4.00%-2.52M

-102,900.00%-2.06M

-740.40%-2.54M

-1,003.43%-5.27M

-634.39%-2.54M

-403.51%-2.42M

-100.69%-2K

-91.14%-302K

33.41%583K

46.02%-346K

Income tax

-35.29%11K

-21.43%11K

64.71%28K

94.29%68K

1,100.00%20K

54.55%17K

16.67%14K

21.43%17K

-53.33%35K

-106.25%-2K

Net income

-3.73%-2.53M

-12,843.75%-2.07M

-704.39%-2.57M

-1,073.54%-5.34M

-644.48%-2.56M

-409.91%-2.44M

-105.78%-16K

-85.47%-319K

51.38%548K

48.89%-344K

Net income continuous Operations

-3.73%-2.53M

-12,843.75%-2.07M

-704.39%-2.57M

-1,073.54%-5.34M

-644.48%-2.56M

-409.91%-2.44M

-105.78%-16K

-85.47%-319K

51.38%548K

48.89%-344K

Minority interest income

Net income attributable to the parent company

-3.73%-2.53M

-12,843.75%-2.07M

-704.39%-2.57M

-1,073.54%-5.34M

-644.48%-2.56M

-409.91%-2.44M

-105.78%-16K

-85.47%-319K

51.38%548K

48.89%-344K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-3.73%-2.53M

-12,843.75%-2.07M

-704.39%-2.57M

-1,073.54%-5.34M

-644.48%-2.56M

-409.91%-2.44M

-105.78%-16K

-85.47%-319K

51.38%548K

48.89%-344K

Basic earnings per share

-5.56%-0.19

-12,579.63%-0.15

-850.00%-0.19

-1,075.00%-0.39

-533.33%-0.19

-400.00%-0.18

-105.92%-0.0012

-100.00%-0.02

33.33%0.04

25.00%-0.03

Diluted earnings per share

-5.56%-0.19

-12,579.63%-0.15

-850.00%-0.19

-1,075.00%-0.39

-533.33%-0.19

-460.00%-0.18

-105.92%-0.0012

-100.00%-0.02

100.00%0.04

25.00%-0.03

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Jan 31, 2024	(Q2)Oct 31, 2023	(Q1)Jul 31, 2023	(FY)Apr 30, 2023	(Q4)Apr 30, 2023	(Q3)Jan 31, 2023	(Q2)Oct 31, 2022	(Q1)Jul 31, 2022	(FY)Apr 30, 2022	(Q4)Apr 30, 2022
Total revenue	-5.90%12.02M	-18.96%11.57M	-8.61%12.56M	9.69%53.87M	1.51%13.07M	-3.18%12.77M	21.17%14.28M	22.15%13.75M	19.66%49.11M	21.90%12.88M
Operating revenue	-7.76%11.18M	-19.73%10.88M	-7.19%11.88M	8.41%50.82M	-0.10%12.35M	-4.13%12.13M	21.60%13.55M	19.30%12.8M	18.27%46.88M	33.17%12.37M
Cost of revenue	1.95%7.85M	-11.08%6.62M	8.96%7.68M	24.97%29.53M	17.96%7.34M	20.18%7.7M	32.70%7.44M	30.69%7.05M	10.19%23.63M	6.47%6.22M
Gross profit	-17.82%4.17M	-27.54%4.96M	-27.13%4.88M	-4.47%24.34M	-13.87%5.73M	-25.24%5.07M	10.70%6.84M	14.27%6.69M	30.02%25.48M	40.99%6.66M
Operating expense	-10.42%6.75M	1.16%6.91M	6.48%7.43M	15.75%28.79M	6.89%7.45M	26.44%7.53M	15.51%6.83M	15.67%6.98M	29.34%24.87M	29.76%6.97M
Selling and administrative expenses	5.33%4.56M	3.97%4.4M	13.35%4.64M	11.27%17.24M	5.00%4.6M	14.67%4.33M	16.93%4.23M	9.71%4.09M	28.79%15.5M	32.69%4.38M
-Selling and marketing expense	2.04%1.8M	5.59%1.8M	0.24%1.7M	9.77%7M	14.49%1.85M	13.69%1.76M	3.66%1.7M	7.50%1.69M	15.56%6.38M	9.71%1.62M
-General and administrative expense	7.59%2.76M	2.89%2.6M	22.60%2.94M	12.32%10.24M	-0.54%2.75M	15.36%2.57M	27.95%2.53M	11.33%2.4M	40.00%9.12M	51.20%2.76M
Research and development costs	-31.73%2.19M	-3.42%2.52M	-3.26%2.79M	23.16%11.55M	10.07%2.85M	46.81%3.2M	13.27%2.6M	25.30%2.89M	30.27%9.37M	25.11%2.59M
Operating profit	-4.84%-2.58M	-28,028.57%-1.96M	-798.59%-2.55M	-832.95%-4.45M	-451.13%-1.71M	-396.14%-2.46M	-97.34%7K	-62.29%-284K	65.85%607K	52.01%-311K
Net non-operating interest income expense
Other net income (expense)	61.11%58K	-1,066.67%-105K	177.78%14K	-3,308.33%-818K	-2,262.86%-827K	212.50%36K	-134.62%-9K	-205.88%-18K	-133.80%-24K	-600.00%-35K
Special income (charges)	----	----	----	---807K	----	----	----	----	--0	----
-Write off	----	----	----	--807K	----	----	----	----	--0	----
Other non- operating income (expenses)	61.11%58K	-1,066.67%-105K	177.78%14K	54.17%-11K	42.86%-20K	212.50%36K	-134.62%-9K	-205.88%-18K	-133.80%-24K	-600.00%-35K
Income before tax	-4.00%-2.52M	-102,900.00%-2.06M	-740.40%-2.54M	-1,003.43%-5.27M	-634.39%-2.54M	-403.51%-2.42M	-100.69%-2K	-91.14%-302K	33.41%583K	46.02%-346K
Income tax	-35.29%11K	-21.43%11K	64.71%28K	94.29%68K	1,100.00%20K	54.55%17K	16.67%14K	21.43%17K	-53.33%35K	-106.25%-2K
Net income	-3.73%-2.53M	-12,843.75%-2.07M	-704.39%-2.57M	-1,073.54%-5.34M	-644.48%-2.56M	-409.91%-2.44M	-105.78%-16K	-85.47%-319K	51.38%548K	48.89%-344K
Net income continuous Operations	-3.73%-2.53M	-12,843.75%-2.07M	-704.39%-2.57M	-1,073.54%-5.34M	-644.48%-2.56M	-409.91%-2.44M	-105.78%-16K	-85.47%-319K	51.38%548K	48.89%-344K
Minority interest income
Net income attributable to the parent company	-3.73%-2.53M	-12,843.75%-2.07M	-704.39%-2.57M	-1,073.54%-5.34M	-644.48%-2.56M	-409.91%-2.44M	-105.78%-16K	-85.47%-319K	51.38%548K	48.89%-344K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-3.73%-2.53M	-12,843.75%-2.07M	-704.39%-2.57M	-1,073.54%-5.34M	-644.48%-2.56M	-409.91%-2.44M	-105.78%-16K	-85.47%-319K	51.38%548K	48.89%-344K
Basic earnings per share	-5.56%-0.19	-12,579.63%-0.15	-850.00%-0.19	-1,075.00%-0.39	-533.33%-0.19	-400.00%-0.18	-105.92%-0.0012	-100.00%-0.02	33.33%0.04	25.00%-0.03
Diluted earnings per share	-5.56%-0.19	-12,579.63%-0.15	-850.00%-0.19	-1,075.00%-0.39	-533.33%-0.19	-460.00%-0.18	-105.92%-0.0012	-100.00%-0.02	100.00%0.04	25.00%-0.03
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall